ARQT - Arcutis shares rally in after-hours trading on FDA approval
2023-12-15 19:02:32 ET
More on Arcutis Biotherapeutics
- Arcutis Biotherapeutics: Almost There, But Needs Some Fine-Tuning
- Arcutis Biotherapeutics, Inc. (ARQT) Q3 2023 Earnings Call Transcript
- Arcutis Biotherapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Arcutis lead product undergoes FDA review for label expansion
- Jones Research downgrades Arcutis to hold, cites loan agreement
For further details see:
Arcutis shares rally in after-hours trading on FDA approval